We demonstrated that CLL cells with high TACI expression (>40%) displayed a better survival capacity compared to CLL cells with low to undetectable TACI expression, when cultured in the presence of BAFF and/or APRIL (Figure 2). The gene discussed is TNFRSF13B; the disease is B-cell chronic lymphocytic leukemia.